Streamlining the dynamin epilepsy drug pipeline. Epilepsy affects up to one percent of Australia's population, yet one in three fail to respond to current medications. Our results will greatly impact on development of future epilepsy therapy. Identification of a new target for epileptic will allow better drug design to improve the potency of our lead drugs. This holds hope that new generation drugs will be more effective. The drugs are predicted to have fewer complications and side-effects. Th ....Streamlining the dynamin epilepsy drug pipeline. Epilepsy affects up to one percent of Australia's population, yet one in three fail to respond to current medications. Our results will greatly impact on development of future epilepsy therapy. Identification of a new target for epileptic will allow better drug design to improve the potency of our lead drugs. This holds hope that new generation drugs will be more effective. The drugs are predicted to have fewer complications and side-effects. The outcome has the potential to vastly improve prospects for up to 200,000 Australians. Intellectual property (IP) retained in Australia will generate future biotechnology industry. The novel chemical biological approaches will facilitate training of future generations of Australian scientists.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0775708
Funder
Australian Research Council
Funding Amount
$289,680.00
Summary
X-ray Diffraction Microscope. The results of the research will substantially expand Australia's knowledge base in the area of diffraction, imaging and structural biology. It will build up our expertise in x-ray optics and synchrotron technology, and will open up a new approach to x-ray imaging and structure determination.
This will revolutionize our understanding of cellular and sub-cellular organisation with implications for the treatment of disease while the ability to determine structures ....X-ray Diffraction Microscope. The results of the research will substantially expand Australia's knowledge base in the area of diffraction, imaging and structural biology. It will build up our expertise in x-ray optics and synchrotron technology, and will open up a new approach to x-ray imaging and structure determination.
This will revolutionize our understanding of cellular and sub-cellular organisation with implications for the treatment of disease while the ability to determine structures of membrane proteins will open the door to fresh opportunities in rational drug design and biotechnology that will promote innovation in this industry, and the likely foundation of new start-up companies.Read moreRead less